Molly Grammel
Goodwin Procter LLPGeneral
Experience12 yrs
Elite Ratings
--
Practice Areas
Biotech (16 cases)
Chemical (4 cases)
Comp. Arch. and Software (3 cases)
Communications (1 case)
Semicond., Optic (2 cases)
Ratings
Experience
Grade
Trend
DCT
L2
D
PTAB
--
--
--
CAFC
--
--
--
Cases
Case # | Court | Caption | Filed | Represent |
|---|---|---|---|---|
| 1:24-CV-00085 | Regeneron Pharma Inc v. Sandoz Inc | 09/13/24 | Challenger | |
| 1:24-CV-00621 | Pfizer Inc v. Apotex Inc | 05/23/24 | Challenger | |
| 1:24-MD-03103 | In Re: Aflibercept Patent Litigation | 04/11/24 | ||
| 5:21-CV-04874 | Novartis Vaccines Diagnostics Inc v. Genentech Inc | 06/24/21 | Challenger | |
| 1:21-CV-10954 | Teva Pharma Intl GmbH v. Eli Lilly Co | 06/07/21 | Patent Owner | |
| 1:20-CV-00690 | Novartis Pharma AG v. Regeneron Pharma Inc | 06/19/20 | ||
| 2:20-CV-03117 | Merck Sharp & Dohme BV v. Sandoz Inc | 03/20/20 | Challenger | |
| 2:20-CV-02909 | Merck Sharp & Dohme BV v. DR Reddys Laboratories Inc | 03/16/20 | Challenger | |
| 2:20-CV-02892 | Merck Sharp & Dohme BV v. Fresenius Kabi USA LLC | 03/16/20 | Challenger | |
| 2:20-CV-02751 | Merck Sharp & Dohme BV v. Teva Pharma USA Inc | 03/12/20 | Challenger |